LOCUS AY487947 1026 bp DNA linear VRL 20-OCT-2004
DEFINITION Human adenovirus E, complete genome.
ACCESSION AY487947 REGION: 16055..17080
VERSION AY487947.1 GI:45504790
KEYWORDS .
SOURCE Human adenovirus E (HAdV-E)
 ORGANISM Human adenovirus E
  Viruses; dsDNA viruses, no RNA stage; Adenoviridae; Mastadenovirus.
REFERENCE 1 (bases 1 to 1026)
 AUTHORS Jacobs,S.C., Davison,A.J., Carr,S., Bennett,A.M., Phillpotts,R. and
 Wilkinson,G.W.G.
 TITLE Characterization and manipulation of the human adenovirus 4 genome
 JOURNAL J. Gen. Virol. 85 (11), 3361-3366 (2004)
 PUBMED 15483252
REFERENCE 2 (bases 1 to 1026)
 AUTHORS  Jacobs,S.C., Davison,A.J., Carr,S., Bennett,A.M., Phillpotts,R. and
 Wilkinson,G.W.G.
 TITLE Direct Submission
 JOURNAL Submitted (26-NOV-2003) University of Wales College of Medicine,
 Department of Medicine, Tenovus Building, Cardiff, Wales CF4 4XX,
 U.K.
REFERENCE 3 (bases 1 to 1026)
 AUTHORS Jacobs,S.C., Davison,A.J., Carr,S., Bennett,A.M., Phillpotts,R. and
 Wilkinson,G.W.G.
 TITLE Direct Submission
  JOURNAL Submitted (30-JUN-2004) University of Wales College of Medicine,
 Department of Medicine, Tenovus Building, Cardiff, Wales CF4 4XX,
 U.K.
FEATURES Location/Qualifiers
 source 1..1026
  /organism="Human adenovirus E"
 /mol_type="genomic DNA"
 /strain="vaccine (CL 68578)"
 /serotype="human adenovirus 4"
 /db_xref="taxon:130308"
 /note="acronym: HAdV-4; acronym: HAdV-E"
 gene complement(<1..>1026)
 /gene="E2B"
 /inference="non-experimental evidence, no additional
 details recorded"
 gene <1..>1026
 /gene="L5"
 /inference="non-experimental evidence, no additional
 details recorded"
 gene <1..>1026
 /gene="L4"
 /inference="non-experimental evidence, no additional
 details recorded"
 gene <1..>1026
 /gene="L3"
 /inference="non-experimental evidence, no additional
 details recorded"
 gene <1..>1026
 /gene="L2"
 /inference="non-experimental evidence, no additional
 details recorded"
 mRNA <1..>1026
 /gene="L2"
 /product="L2 III"
 /inference="non-experimental evidence, no additional
 details recorded"
 mRNA <1..>1026
 /gene="L2"
 /product="L2 pVII"
 /inference="non-experimental evidence, no additional
 details recorded"
 mRNA <1..>1026
 /gene="L2"
  /product="L2 V"
 /inference="non-experimental evidence, no additional
 details recorded"
 CDS 1..1026
 /gene="L2"
 /inference="non-experimental evidence, no additional
 details recorded"
 /codon_start=1
 /product="V"
 /protein_id="AAS66922.1"
 /db_xref="GI:45504802"
 /translation="MSKRKFKEEMLQVIAPEIYGPAAAVKDERNPRKIKRVKKDKKEE
 DDVDDMVEFVREFAPRRRVQWRGRKVRPVLRPGTTVVFAPGERSGTTSKRSYDEVYGD
 EDILEQAAERLGEFAYGKRNRLAPLKEEVVSIPLDHGNPTPSLKPVTLQQVLPSAAPR
 RGLKREGEDVYPTMQLMVPKRQKLEDVLETMKVDPDVQPEVKVRPIKQVAPGLGVQTV
 DIKIPTEPMETQTEVVKPITSTMEVQTDPWMPAAPRKPRRKYGAASLLMPNYALHPSI
 IPTPGYRGTRFYHGYTGSRRRKTTTRRRRRRTAATPAAALVRRVYRRGRAPLTLPRAR
 YHPSITI"
ORIGIN 
 1 atgtccaagc gcaaattcaa ggaagagatg ctccaggtca tcgcgcctga gatctacggc
 61 cccgcggcgg cggtgaagga tgaaagaaat ccccgcaaaa tcaagcgggt caaaaaggac
 121 aaaaaggaag aagatgatgt ggacgatatg gtagagtttg tgcgcgagtt tgccccccgg
 181 aggcgcgtgc agtggcgcgg gcggaaagtg cgtccggtgc tgagacccgg caccacggtg
 241 gttttcgcgc ctggcgagcg gtccggcacg acatccaagc gctcctacga tgaggtgtac
 301 ggggacgagg atattctcga gcaggcggcc gagcgcctgg gcgagtttgc ttacggcaag
  361 cgcaaccgcc ttgcgcccct gaaggaagag gtggtgtcca tcccgctgga ccacggcaac
 421 cccacgccga gtcttaagcc cgtgaccctg cagcaggtgc tgccgagcgc ggcgccgcgt
 481 cggggcttga agcgcgaggg cgaggatgtg taccccacca tgcagctgat ggtgcccaag
 541 cgccagaagc tggaagacgt gctggagacc atgaaggtgg acccggacgt gcagcccgag
 601 gtcaaggtga ggcccatcaa gcaggtggcc ccgggccttg gcgtgcagac cgtggacatc
 661 aagatcccca cggagcccat ggaaacgcag accgaggtcg tgaagcccat caccagcacc
 721 atggaggtgc agacggatcc ttggatgccg gcggcgcccc gaaaaccccg gcgcaagtac
 781 ggcgcggcca gcctgctgat gcccaactac gcgctgcatc cttccatcat ccccacgccg
 841 ggctaccgcg gcacgcgctt ctaccacggc tataccggct cccgccgccg caagaccacc
 901 acccgccgcc gtcgtcgccg cacagctgca actcccgctg ccgccctggt gcggagagtg
 961 taccgccgcg gccgcgcgcc tctgaccctg ccgcgggcgc gctaccaccc gagcattacc
 1021 atttaa
//